Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Explore innovative ways to get paid instantly without needing a traditional job. These options can provide quick financial relief.
20,854 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Bitcoin steadies around the mid-50s as XRP, Solana, and PEPE push higher on evolving policy signals and renewed inves...
Oil futures fell about 8% as energy ministers prepared to discuss emergency reserve releases. The move comes amid ong...
A USD EM bond ETF is delivering about 5.4% yield, drawing retirees to its monthly payouts. This piece examines income...
Polymarket is adopting an AI-driven monitoring system from Palantir and TWG Global to police betting activity in real...
A once-hot cybersecurity stock has fallen 40%, yet a large investor just increased exposure. This guide breaks down w...
Binance filed a defamation lawsuit against The Wall Street Journal in New York, challenging a February report on Iran...
Markets tremble as macro fears and geopolitics rise. Three safer dividend ETFs to pursue offer steadier income, lower...
Wednesday brought an outsized move for Sprinklr as earnings beat and optimism around CXM services spurred fresh buyin...
In a higher-rate market, four ETFs are delivering standout income. This report breaks down JEPI, BIZD, SDIV and KNG, ...
As Vivid Seats reports Q4 2025 results, investors face a pivotal moment. This article breaks down revenue drivers, ma...
New Jersey's budget proposal would trim senior property tax relief by tightening Stay NJ and related programs, as law...